MedPath

SERTRALINE HYDROCHLORIDE

SERTRALINE HYDROCHLORIDE Tablets and Oral Concentrate

Approved
Approval ID

13bbfcfe-24c8-4ca5-b119-918d1ab7aa37

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 8, 2010

Manufacturers
FDA

State of Florida DOH Central Pharmacy

DUNS: 829348114

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

sertraline hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code53808-0582
Application NumberNDA019839
Product Classification
M
Marketing Category
C73594
G
Generic Name
sertraline hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateJune 8, 2010
FDA Product Classification

INGREDIENTS (10)

SERTRALINE HYDROCHLORIDEActive
Quantity: 100 mg in 1 1
Code: UTI8907Y6X
Classification: ACTIB
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
HYDROXYPROPYL CELLULOSEInactive
Code: RFW2ET671P
Classification: IACT
HYPROMELLOSEInactive
Code: 3NXW29V3WO
Classification: IACT
POLYETHYLENE GLYCOLInactive
Code: 3WJQ0SDW1A
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SERTRALINE HYDROCHLORIDE - FDA Drug Approval Details